Glucocorticoids reduced the duration of mechanical ventilation duration and vasoactive drug use in sCAP patients without increasing the risk of adverse events including hyperglycemia and multiple infections. However, there was no significant difference in mortality or length of hospital stay in sCAP patients between glucocorticoid and non-glucocorticoid groups. Glucocorticoids could be recommended for patients with sCAP with respiratory failure or hemodynamic instability.
Keyphrases
- mechanical ventilation
- end stage renal disease
- respiratory failure
- chronic kidney disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- acute respiratory distress syndrome
- community acquired pneumonia
- type diabetes
- emergency department
- systematic review
- clinical trial
- cardiovascular disease
- patient reported outcomes
- early onset
- risk factors
- cardiovascular events